Browse > Article

Two cases of postoperative chylothorax treated with parenteral octreotide and conservative therapy  

Choi, Eun Jin (Department of Pediatrics, Catholic University of Daegu School of Medicine)
Lee, Sub (Department of Thoracic and Cardiovascular Surgery, Catholic University of Daegu School of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.3, 2007 , pp. 298-301 More about this Journal
Abstract
Chylothorax is a rare complication following cardiac surgery for congenital heart diseases. Although conservative management is successful in the majority of cases, surgical intervention is required in a refractory one. Recently, subcutaneous or intravenous infusion of octreotide has been used as a safe treatment that helps avoiding surgical intervention. Herein, we report two cases of postoperative chylothorax treated with parenteral octreotide and conservative therapy.
Keywords
Chylothorax; Postoperative Complications; Octreotide; Parenteral;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Buettiker V, Hug MI, Burger R, Baenziger O. Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med 2001;27:1083-6   DOI   ScienceOn
2 Kelly RF, Shumway SJ. Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg 2000;69:1944-5   DOI   ScienceOn
3 Allen EM, van Heeckeren DW, Spector ML, Blumer JL. Management of nutritional and infectious complications of postoperative chylothorax in children. J Pediatr Surg 1991; 26:1169-74   DOI   ScienceOn
4 Nakabayashi H, Sagara H, Usukura N, Yoshimitsu K, Imamura T, Seta T. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes 1981;30:440-5   DOI
5 Nguyen DM, Shum-Tim D, Dobell AR, Tchervenkov CI. The management of chylothorax/chylopericardium following pediatric cardiac surgery: a 10-year experience. J Card Surg 1995;10:302-8   DOI   ScienceOn
6 Rimensberger PC, Muller-Schenker B, Kalangos A, Beghetti M. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 1998;66:253-4   DOI   ScienceOn
7 Rosti L, De Battisti F, Butera G, Cirri S, Chessa M, Delogu A, Drago M, Giamberti A, Pome G, Carminati M, Frigiola A. Octreotide in the management of postoperative chylothorax. Pediatr Cardiol 2005;26:440-3   DOI   ScienceOn
8 Peitersen B, Jakobsen B. Medium chain triglycerides for treatment of spontaneous neonatal chylothorax. Acta Paediatr Scand 1977;66:121-5
9 Pratap U, Slavik Z, Ofoe VD, Franklin R. Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg 2001;72:1740-2.   DOI   ScienceOn
10 Grosman I, Simon D. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am J Gastroenterol 1990;85:1061-72
11 Rasiah SV, Oei J, Lui K. Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health 2004;40: 585-8   DOI   ScienceOn
12 Rosti L, Bini RM, Chessa M, Butera G, Drago M, Carminati M. The effectiveness of octreotide in the treatment of postoperative chylothorax. Eur J Pediatr 2002;161:149-50   DOI   ScienceOn
13 Chan EH, Russell JL, Williams WG, Van Arsdell GS, Coles JG, McCrindle BW. Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 2005; 80:1864-71   DOI   ScienceOn
14 Cheung Y, Leung MP, Yip M. Octreotide for treatment of postoperative chylothorax. J Pediatr 2001;139:157-9   DOI   ScienceOn